More News

15 May 2019 Vertex and Kymera Therapeutics Establish Strategic Collaboration to Discover and Develop Targeted Protein Degradation Medicines for Serious Diseases
15 May 2019 Adaptimmune and Alpine Immune Sciences Announce Collaboration and License Agreement to Develop Next-Generation SPEAR T-Cell Products
14 May 2019 Zymeworks Enters its First ZymeLink™ Antibody-Drug Conjugate Platform Licensing Agreement with Iconic Therapeutics
12 May 2019 TriSalus Life Sciences’ Pressure-Enabled Drug Delivery (PEDD) Increases Penetration and Antitumor Activity of Anti-CEA CAR-T in Mouse Model of Liver Metastases
10 May 2019 Spectrum Announces Asset Purchase and License for a Novel Immuno-Oncology Platform including Two Early Stage Assets
10 May 2019 Takeda Simplifies Portfolio and Accelerates Deleveraging Through Two Divestitures
09 May 2019 Novartis to acquire Xiidra®, expanding front-of-eye portfolio and strengthening leadership in eye care
08 May 2019 Protagonist Therapeutics Expands PTG-200 Collaboration Agreement with Janssen to Include Second Generation Oral IL-23 Receptor Antagonists
08 May 2019 Curadev Announces Licensing Agreement With Takeda for Novel STING Agonist
08 May 2019 Gilead Sciences and Goldfinch Bio Announce Strategic Collaboration to Develop Novel Therapies for Kidney Disease
08 May 2019 BioNTech Acquires MabVax Therapeutics’ Antibody Assets to Expand Portfolio
08 May 2019 Pfizer Acquires Clinical-Stage Biotech Therachon
06 May 2019 Skyhawk Therapeutics Announces Agreement with Takeda to Develop Novel Small Molecule RNA Splicing Modifiers for Neurodegenerative Diseases
03 May 2019 Amgen And Syapse Enter Precision Medicine Collaboration In Oncology
02 May 2019 Transgene and AstraZeneca enter into a collaboration and exclusive license option agreement for innovative Invir.IOTM based armed oncolytic immunotherapies
01 May 2019 Tmunity and UC San Francisco Announce Exclusive License and Research Collaboration to Advance TCR T Cell Therapies for Pediatric Cancers
01 May 2019 AstraZeneca starts artificial intelligence collaboration to accelerate drug discovery
30 Apr 2019 Sandoz enters agreement for proposed trastuzumab biosimilar, currently in Phase III development, to treat selected HER2-positive cancer tumors
29 Apr 2019 Iktos Announces Research Collaboration with Janssen to Utilize Iktos’ Artificial Intelligence Technology to Increase Speed & Efficiency of Small Molecule Drug Discovery
29 Apr 2019 Calixar signs exclusive licensing agreement with Regeneron on undisclosed therapeutic target
25 Apr 2019 Daiichi Sankyo Selects Lead Candidate Built on Zymeworks’ Azymetric™ Bispecific Platform
25 Apr 2019 Salix Enters Into Exclusive License Agreement With Mitsubishi Tanabe Pharma To Develop And Commercialize Late Stage Investigational S1P Modulator For The Treatment Of Inflammatory Bowel Disease
24 Apr 2019 ADC Therapeutics and Adagene Announce License Agreement
23 Apr 2019 Lilly and Avidity Biosciences Announce Licensing and Research Collaboration
23 Apr 2019 Variant Pharmaceuticals Expands Development Focus Into $60+ Billion Anti-inflammatory Market with Worldwide License to Novel Inflammasome Inhibitor

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up